This poster presents an evaluation of outcomes in cystic fibrosis (CF) patients within a health system specialty pharmacy care model by comparing them to established benchmarks.
This poster spotlights our collaboration with NYULangone Health and highlights how the success of an ambulatory pharmacist-led program within an HSSP in efficiently handling mavacamten therapy and REMS program requirements…
The Shields Health Solutions care model for helping pharmacies and providers treat patients with pulmonary arterial hypertension (PAH) integrates a patient’s entire care team, and can be adopted to successfully…
This research poster examines the innovative clinical management model that was developed and implemented at four health system specialty pharmacies, allowing dispensing of ambrisentan, a specialty medication with a required…
As we recognize amyotrophic lateral sclerosis (ALS) Awareness Month in May, the disease remains without a cure. A rare and fatal neurodegenerative disease characterized by a progressive degeneration of motor…
This white paper discusses how health system-owned specialty pharmacies leveraging Shields’ integrated care model, data aggregation and acceleration solutions can overcome challenges and barriers to care for specialty patients with…
This post was originally published in November 23, 2021 and updated on November 3, 2022. November is Pulmonary Hypertension Awareness Month, an annual event to raise awareness of this rare…
September is National Sickle Cell Awareness Month as designated by Congress to help focus attention on the need for research and treatment of sickle cell disease (SCD). Sickle cell disease…
This white paper explores how a high-touch integrated specialty pharmacy care model can help patients with cystic fibrosis manage the complexity of their treatment regimen and achieve their therapy goals.…